Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    J Nucl Med. 2011 Jul;52(7):1005-8. doi: 10.2967/jnumed.110.084244. Epub 2011 Jun 16.

    Role of glutamine in cancer: therapeutic and imaging implications.

    Source

    Department of Pediatrics and McDermott Center for Human Growth and Development, University of Texas-Southwestern Medical Center, Dallas, Texas 75390-9063, USA.

    Abstract

    Metabolic imaging has great clinical potential in cancer because perturbations of metabolism are common hallmarks of malignant cellular transformation. Novel imaging strategies focused on glutamine could provide a valuable complement to (18)F-FDG PET, because glutamine complements glucose in the metabolic platforms that support tumor growth at the cellular level. Furthermore, recent work has demonstrated that distinct aspects of glutamine metabolism are under the control of oncogenes and tumor suppressors. It is plausible that imaging glutamine metabolism could predict both the presence of specific transforming mutations in the tumor and the sensitivity to therapeutic agents designed to target glutamine use. Here, we review the essential aspects of glutamine metabolism in cancer cells and discuss opportunities for imaging in cancer patients.

    PMID:
    21680688
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3337771
    Free PMC Article

    Images from this publication.See all images (1)Free text

    Figure 1

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk